NEW YORK (GenomeWeb News) – BioFire Diagnostics has appointed Robert Lollini as CFO.

Lollini most recently served as CEO, and formerly as CFO of Myrexis, a Utah-based biotechnology company. He remains a member of its board of directors. From 1993 to 2007, Lollini held multiple executive positions at drug-delivery company Iomed, which was acquired in May 2007. Earlier in his career, he held various executive management positions at RP Scherer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.